The earnings this week calendar looked quiet on Monday and has been anything but since. Apple and Palantir both fell after reporting, AMD jumped after the bell, and Marvell agreed to buy Lumentum in a $115 billion all-stock deal. The busiest stretch is still ahead: Qualcomm and AppLovin report Wednesday night, Airbnb, Cloudflare, IonQ and SoundHound follow Thursday, and Moderna, Oklo and Humana arrive Friday before the October jobs report. Here are ten stocks still to report this week, each with a full data table, options-implied move, support and resistance, a bull and bear case with prices, and a forecast.

Earnings This Week: Tuesday’s Market Snapshot Before the Back Half

Fool.com’s close report shows chip stocks ending the Nasdaq’s three-session losing streak on Election Day, while Apple dragged the Dow. Oil fell sharply, a relief after Brent rose about 14% in October to $113.43, and the Fed has held rates at 3.75% to 4.00%.

What has already happened this week:

• Apple (-2.63% Tuesday): Record revenue, but a margin warning tied to rising memory-chip costs weighed on the stock.
• Palantir (-1.65% Tuesday): It beat and raised, but investors focused on slower new bookings and valuation.
• AMD: Shares rose nearly 5% after hours on strong results.
• Marvell and Lumentum: The all-stock deal sent Lumentum down 18.6% Monday, which TNN covered in its Nov. 3 stocks-to-watch list.
• Also reported: Shopify, Pfizer and Eaton reported Tuesday, and StockTitan counts 750 companies worth $2 billion or more reporting Nov. 2 to 6.

Data note: Closes are Nov. 3 regular-session prints where available. Figures marked “about” or “derived” come from reported moves or quotes, “n/v” means not verified, and implied moves come from options data published by TipRanks, Investing.com, OptionScout and Schaeffer’s. Support and resistance levels are analytical zones, not guarantees.

Earnings This Week: The Full Nov. 1-8 Calendar for the Stocks to Watch

1. Qualcomm (QCOM) | Last Price Near $164 | Reports Wednesday After the Close | ±9.6% Implied Move

A Handset Giant Down 11% in a Month Tries to Prove the Data-Center Story Before Apple and Memory Costs Bite

Catalyst & latest news: Qualcomm reports fiscal Q4 after the close with a 4:45 p.m. ET call. MarketBeat lists consensus at $2.17 in non-GAAP EPS on $10.14B in revenue, and Schaeffer’s notes both are down about 28% and 10% from a year ago. BigGo reports management expects non-handset revenue growth to accelerate from 24% in fiscal 2026 to more than 60% in fiscal 2027, while tight memory supply is expected to weigh on several phone makers.

Technicals: QCOM traded near $163.50 to $164.79 on Nov. 3, down about 4.5% year to date. It is below its 50-day average near $176.83 and 200-day near $169.42, and options imply a move of roughly 8.8% to 10%, or a range of about $148 to $181. The stock finished higher after only three of its last 12 reports, averaging a 1.6% loss, though it jumped 15.1% after April’s.

Fundamentals:

Fiscal 2027 EPS estimates are about $7.17 to $10.02 depending on the source, and the stock trades near 16x forward earnings, below the S&P 500’s roughly 19x. Bernstein’s Stacy Rasgon kept a Hold and cut his target to $155 from $165.

Scenarios: Bullish: a beat and a strong non-handset outlook push through $169.42 toward $177 to $181. Base: a 5% to 8% move that stays inside $155 to $176. Bearish: weak handset guidance breaks $160 and tests $148.

Bull case: A 16x multiple, a 60% non-handset growth target and a stock that averaged a 7.5% post-earnings swing could rebound toward $181. Bear case: Falling revenue, memory-cost pressure on phone makers and a poor post-earnings record could send the stock to $155 or $148.

What to watch:

• First-quarter fiscal 2027 guidance versus a Street near $10B
• Data-center and automotive revenue commentary
• Handset demand and Apple-related remarks

Forecast: Holding $160 keeps $169 to $177 in play. A break targets $148 to $155.

Why this matters: Qualcomm is the first real test of whether chip names can recover after Apple’s memory-cost warning.

2. AppLovin (APP) | Last Price About $241.79 | Reports Wednesday After the Close | ±17% Implied Move

One of the S&P 500’s Worst Stocks This Year Bounces Off a 52-Week Low, With Two Straight 19.7% Earnings Drops Behind It

Catalyst & latest news: AppLovin reports Q3 with a 5:00 p.m. ET call. Analysts expect adjusted EPS of $3.94 to $4.09, up about 61%, on revenue of $2.08B to $2.10B, up about 48%, according to Schaeffer’s. The stock fell 19.7% after both its August and February reports, and options imply a move of about 17%.

Technicals: APP was up about 5.7% at $241.79 on Nov. 3 after hitting a 52-week low of $225.19 on Oct. 30. It is far below its 50-day average near $297.87 and 200-day near $423.48. Investing.com noted it has exceeded the implied move in five of eight reports, including a 43.1% jump in November 2024.

Fundamentals:

Q2 EPS of $3.76 matched estimates with revenue up 52.8%. The stock is down 53% over 12 months, beta is 2.56, and MarketBeat shows a market cap near $87B at $259 and an average target of about $494.

Scenarios: Bullish: a beat and raised guidance reclaim $259 to $262 and run toward $298. Base: a 10% to 15% move that ends near $215 to $275. Bearish: a third straight 19.7% drop breaks $225 and heads toward $200.

Bull case: A 60% EPS growth rate, a trailing P/E near 19 and a $483 average target imply deep upside from $242 if growth holds. Bear case: Two straight 19.7% post-earnings losses, a stock 43% below its 200-day average and a break under $225.19 could target $200.

What to watch:

• Revenue versus about $2.1B and Q4 guidance
• E-commerce ad-network traction and margin commentary
• Whether $225.19 holds as support

Forecast: Holding $225.19 keeps $259 to $262 in play. A break targets $200.

Why this matters: AppLovin is the week’s highest-volatility name, and its reaction will color sentiment on ad-tech and AI-software stocks.

3. Celsius Holdings (CELH) | Last Price About $29.96 | Reports Thursday Before the Open | ±10% to 12% Implied Move

A $7.6 Billion Energy-Drink Stock Faces a Test After Its 18% Drop in August

Catalyst & latest news: Celsius reports before the open with an 8:00 a.m. ET call. Analysts expect EPS of about $0.34 to $0.35, against a year-ago loss of $0.27, on revenue of $800M to $816M, per MarketBeat. Yahoo Finance notes analysts are watching Alani Nu, Rockstar integration savings, international expansion, inventory and promotional costs. JPMorgan trimmed its target to $48 from $52 on Oct. 26.

Technicals: CELH traded near $29.96 and fell 18.46% the day after its August report. OptionScout puts the implied range at about $25.74 to $32.80, a move of about 12%.

Fundamentals:

Q2 revenue was $817.9M with net income of $36.4M, a 4.45% margin. Trailing EPS is $0.23, a P/E near 130, and Q2 EPS of $0.36 missed the $0.41 estimate. Fourteen analysts rate the stock Buy, six Hold and one Sell, with an average target of $41.10 and a range of $26 to $64.

Scenarios: Bullish: a revenue beat and Alani Nu strength lift it toward $32.80 to $35. Base: a 6% to 10% move in either direction. Bearish: margin or volume weakness breaks $27.98 and targets $25.74.

Bull case: EPS swinging to profit, a $41 average target and 14 Buy ratings imply about 37% upside from $30. Bear case: A P/E near 130, an 18% drop last time and a Deutsche Bank Hold at $35 could send the stock to $26.

What to watch:

• Alani Nu and Rockstar volume and pricing
• Gross margin and promotional spending
• Full-year commentary after August’s miss

Forecast: Holding $27.98 keeps $30 to $32.80 in play. A break targets $25.74 to $26.

Why this matters: Celsius is a read on consumer spending on premium energy drinks and on whether recent acquisitions are paying off.

4. Airbnb (ABNB) | Last Price About $172.84 (+5.14%) | Reports Thursday After the Close | ±6.7% Implied Move

A Host-Rules Controversy, Three Misses in Four Quarters and a 30% EPS Growth Bar

Catalyst & latest news: Airbnb reports Q3 with a 5:00 p.m. ET call. Analysts expect EPS of $2.85 to $2.89, up about 30% from $2.21, on revenue of $4.75B, up about 16%, inside the company’s $4.69B to $4.77B guide. Benzinga reports a new standard-rules policy for hosts rattled sentiment, and Airbnb has beaten EPS estimates only once in the past four quarters.

Technicals: ABNB traded near $172.84, up 5.14% after a $168.86 close. It sits above its 50-day average near $171.20 and 200-day near $146.41, and Investing.com’s options data implies a 6.7% move. Shares fell 8% after the August report despite a beat.

Fundamentals:

Market cap is about $103B, trailing P/E near 39x (derived), and the PEG ratio is about 1.9. Barchart’s survey of 40 analysts shows 20 Strong Buy and 14 Hold with an average target of $185.45.

Scenarios: Bullish: a beat and firm Q4 guidance lift it toward $182 to $185. Base: a 4% to 7% move. Bearish: soft guidance breaks $171 and tests $162.

Bull case: 30% EPS growth, a 15% to 17% revenue growth guide and a $185 target imply about 7% upside from $173. Bear case: A history of misses, an 8% drop in August and a 39x P/E could send the stock to $166 or $162.

What to watch:

• Q4 revenue guidance versus the Street
• Nights booked growth and AI-search commentary
• Host supply and the new rules rollout

Forecast: Holding $171.20 keeps $182 to $185 in play. A break targets $162 to $166.

Why this matters: Airbnb is the week’s cleanest read on consumer travel demand going into the holidays.

5. Cloudflare (NET) | Last Price About $271.88 | Reports Thursday After the Close | ±11% Implied Move

A $96 Billion Edge-Network Stock Down 14% in a Week Goes Into Earnings With a JPMorgan Upgrade

Catalyst & latest news: Cloudflare reports Q3 with a 5:00 p.m. ET call and has guided to revenue of $736M to $737M and adjusted EPS of $0.34. Consensus is $0.34 to $0.35 on about $733M to $737M, up about 31%, per Yahoo Finance, and the company has beaten EPS in each of the last four quarters. JPMorgan upgraded the stock to Overweight on Nov. 3 with a $350 target.

Technicals: NET traded near $271.88, well below its 50-day average near $320 and above its 200-day near $246.69. Its 52-week range is $158.83 to $370.35, and Investing.com’s options data implies an 11% move. Software peers sold off hard after results, with F5 down 20.4% and Twilio down 15.2%.

Fundamentals:

Q2 revenue was $696.1M, up 35.9%, and dollar-based net retention improved to 120%. Gross margins face pressure from AI workloads, and the stock trades near 50 times sales. Full-year EPS guidance is $1.25 to $1.26.

Scenarios: Bullish: a beat and raised guide lift it toward $303 to $318. Base: a 7% to 11% move that ends between $250 and $300. Bearish: margin worries break $264.86 and test the 200-day near $246.69.

Bull case: 31% growth, a four-quarter beat streak and a $345 average target imply about 27% upside from $272. Bear case: A 50x sales multiple, a software-sector rout and gross-margin pressure could send the stock to $247 or $225.

What to watch:

• Gross margin and AI-workload commentary
• Large-customer count and net retention
• Peer reactions after F5 and Twilio

Forecast: Holding $264.86 keeps $303 to $318 in play. A break targets $247.

Why this matters: Cloudflare tells investors whether the software selloff has gone far enough or has further to run.

6. IonQ (IONQ) | Last Verified Close $30.04 | Reports Thursday After the Close | ±11% to 13% Implied Move

A Quantum Stock Down 30% This Year Heads Into Earnings With a $1.8 Billion Acquisition and a $2 Billion Offering Hanging Over It

Catalyst & latest news: IonQ reports Q3 after the close with a 4:30 p.m. ET call. Analysts expect a loss of $0.34 per share, versus a $3.58 loss a year ago, on revenue of about $141.2M, up roughly 254%, according to TipRanks. The company raised 2026 revenue guidance to $450M to $460M and is integrating its $1.8B SkyWater purchase. Traders Union reports investors also want updates on a planned $1.3B Elisity acquisition and a $2.0B offering.

Technicals: IONQ closed at $30.04 on Oct. 30 and has traded as low as about $28.17 since. It broke under the prior weekly low of $29.99, sits far below its 50-day average near $38.66 and 200-day near $42.28, and TipRanks’ options math implies a move of about 11.4%, or a range of $26.62 to $33.46.

Fundamentals:

Q2 revenue was $80.05M, up 286.7%, and the company remains deeply unprofitable. Market cap is about $13.9B, beta is 3.36 and the average analyst target is about $62 to $68, with 46 of 54 analysts rating the stock a buy.

Scenarios: Bullish: a revenue beat and clean SkyWater integration lift it toward $33.46 and the 50-day near $38.66. Base: a 10% to 13% move either way. Bearish: dilution or a guidance miss breaks $28.17 and tests $26.62.

Bull case: 254% revenue growth, a raised outlook and a $62 average target imply about 100% upside from $30. Bear case: A beta above 3, a $2.0B offering and a 30% year-to-date decline could take the stock to $26.62 or $25.

What to watch:

• Revenue versus about $141M and the $450M to $460M guide
• Details of the $2.0B offering and Elisity deal
• SkyWater integration costs and margins

Forecast: Holding $28.17 keeps $30 to $33.46 in play. A break targets $26.62.

Why this matters: IonQ is a high-beta read on whether quantum computing can fund its ambitions without heavy dilution.

7. SoundHound AI (SOUN) | Last Close $4.22 (-3.21%) | Reports Thursday After the Close | ±12% Implied Move

A $1.9 Billion Voice-AI Stock Down 59% This Year Sits Right at Its 52-Week Low Before Earnings

Catalyst & latest news: SoundHound reports Q3 with a 5:00 p.m. ET call. MarketBeat’s consensus is a loss of about $0.125 per share on revenue of $61.71M, up roughly 47%, with full-year revenue guided to $230M to $260M. The Motley Fool notes analysts see revenue near $77M once the LivePerson acquisition is counted, and a TipRanks preview says options imply a move of about 12.7%.

Technicals: SOUN closed at $4.22 on Oct. 30, down 3.21%, with a day range of $4.04 to $4.24 and a 52-week range of $4.04 to $17.85, so it is trading at the low end. The stock rose 10.1% after its August report but has fallen about 32% since.

Fundamentals:

Q2 revenue was $61.9M against a $52.4M estimate, non-GAAP gross margin was 58.4% and the adjusted loss narrowed to $0.02 per share. Zacks sees a positive earnings ESP of about 33%. The stock trades near nine times sales, and the average analyst target is about $11.

Scenarios: Bullish: a beat and a raised guide push it past $4.44 toward $5. Base: a 10% to 12% move that stays between $3.70 and $4.74. Bearish: a miss breaks the 52-week low at $4.04 and heads to $3.70.

Bull case: A 47% revenue growth rate, a narrowing loss and a $11 average target imply about 160% upside from $4.22. Bear case: A 59% year-to-date decline, cash-burn concerns and a break under $4.04 could target $3.70 or $3.50.

What to watch:

• The updated full-year revenue guide
• Organic growth once LivePerson is stripped out
• Adjusted EBITDA and cash burn

Forecast: Holding $4.04 keeps $4.44 to $4.74 in play. A break targets $3.70.

Why this matters: SoundHound shows how far AI small caps have fallen and how much a single quarter can matter for sentiment.

8. Moderna (MRNA) | Last Price $231.30 (+4.7%) | Reports Friday Before the Open | Up About 280% Since Its Last Report

A Stock Trading at More Than Twice Its Average Analyst Target Faces a Loss of $1.10 a Share on $890 Million in Revenue

Catalyst & latest news: Moderna reports Q3 before the open Friday with an 8:00 a.m. ET call. MarketBeat lists consensus at a loss of $1.10 per share on revenue of about $890M, while Zacks has the loss at $1.37. Earnings Whispers shows the stock up about 283% since its July 31 report, when revenue of $145M beat the $102.9M estimate.

Technicals: MRNA traded at $231.30 on Nov. 3 versus a $220.83 prior close. It sits far above its 50-day average near $180.72 and 200-day near $85.58, and the average analyst target is only about $107, so the stock trades at more than double the Street’s consensus. An options-implied move was not verified.

Fundamentals:

The company targets up to 10% revenue growth in 2026 with year-end cash of $4.5B to $5.0B and 2026 operating expenses near $4.7B, per its first-quarter 8-K. Full-year EPS estimates are a loss of $6.11 to $8.52, and the stock trades near 34 times forward sales. Analysts rate it six Buy, fifteen Hold and four Sell.

Scenarios: Bullish: a revenue beat and upbeat pipeline news hold $231 and extend toward $250. Base: a wide, two-way session between $210 and $245. Bearish: a miss breaks $220.83 and reopens $200 and the 50-day near $180.72.

Bull case: A narrower loss, a revenue beat and a flu-vaccine and oncology pipeline could carry the stock from $231 toward $250. Bear case: A price at twice the consensus target, a 34x sales multiple and a gap that has risen about 280% could fall to $200 or $181.

What to watch:

• Revenue versus about $890M and 2026 guidance
• Year-end cash and operating-expense updates
• Flu, combination-vaccine and cancer-therapy milestones

Forecast: Holding $220.83 keeps $231 to $250 in play. A break targets $200.

Why this matters: Moderna is the week’s clearest test of whether a historic rally can survive a hard look at the numbers.

9. Oklo (OKLO) | Last Close $23.49 (-0.13%) | Reports Friday Before the Open | ±10% to 14% Implied Move

A Nuclear Stock Down 62% This Year Faces Seven Price-Target Cuts and a $1 Million Revenue Line

Catalyst & latest news: Oklo reports Q3 before the open Friday with an 8:30 a.m. ET call, as the company announced. MarketBeat lists consensus at a loss of about $0.27 per share on revenue near $1.0M. Truist cut its target to $31 from $51, Citi to $33 from $57.50, Piper Sandler to $49 and Barclays to $59. Management has said initial isotope revenue is more likely in early 2027, Zacks notes.

Technicals: OKLO closed at $23.49 after $23.52 on Nov. 2, $25.25 on Oct. 30 and $27.12 on Oct. 28. It is far below its 50-day average near $35.86 and 200-day near $54.53, and GuruFocus reports options imply a move of about 13.6%, or $3.19.

Fundamentals:

Oklo posted a loss of $0.28 versus a $0.16 estimate last quarter. Its price-to-sales ratio is in the thousands, trailing P/E is negative, and the average analyst target of about $65 sits roughly 178% above the price.

Scenarios: Bullish: licensing or reactor-timeline news lift it toward $25 to $27. Base: a 10% to 14% move. Bearish: another miss or further target cuts break $22 and test $20.

Bull case: A $65 average target, a possible reactor-timeline update and a stock down 62% could rebound toward $27. Bear case: Seven recent target cuts, no meaningful revenue and a stock 35% below its 50-day average could slide to $22 or $20.

What to watch:

• Reactor, fuel and licensing milestones
• Cash position and spending
• Any further target changes on Friday

Forecast: Holding $23.49 keeps $25 to $27 in play. A break targets $20 to $22.

Why this matters: Oklo shows how pre-revenue nuclear names trade on timelines, and Friday’s call is a timeline check.

10. Humana (HUM) | Last Price About $410 | Reports Friday Before the Open | ±8.2% Implied Move

A Loss of $1 a Share Is the Plan: Medicare Advantage Insurer Near Its 52-Week High After 95% Star-Rating Upgrade

Catalyst & latest news: Humana reports Q3 at 6:00 a.m. ET with an 8:00 a.m. call, and Wall Street expects a loss of $1.00 to $1.03 per share on revenue of $40.87B versus a $3.24 profit a year ago, according to TradingView. The company beat EPS in each of the last four quarters, including $7.61 against $7.27 in Q2. Raymond James upgraded the stock to Outperform with a $520 target as 4-star-plus Medicare Advantage membership is set to reach 95% for 2027 from 41% in 2026.

Technicals: HUM traded near $410 versus an Oct. 30 open of $415.55 and a 52-week range of $163.11 to $456.50. Investing.com notes options imply an 8.2% move, but the stock has moved more than implied in six of eight reports, including a 9.6% drop on July 29 despite a beat.

Fundamentals:

Market cap is about $49.3B, trailing P/E is 38.8 on EPS of $10.58, the dividend is $3.54 (0.86%) and beta is 0.64. The average analyst target is $465 with a range of $280 to $596, and Mizuho raised its target to $495 on Oct. 13.

Scenarios: Bullish: a smaller-than-expected loss and firm 2027 commentary lift it toward $436 to $456. Base: a 5% to 8% move either way. Bearish: cost-trend worries break $400 and test $380.

Bull case: A four-quarter beat streak, a star-ratings tailwind and a $465 to $520 target range imply about 13% to 27% upside from $410. Bear case: A 39x trailing P/E, a record of moving more than implied and a 9.6% drop last time could send the stock to $380 or $350.

What to watch:

• Medical-cost trend versus the Street
• 2027 margin and Medicare Advantage membership commentary
• Whether the stock holds $400 after the print

Forecast: Holding $400 keeps $415 to $436 in play. A break targets $380.

Why this matters: Humana is the health-insurance read of the week, and Friday’s margin commentary reaches the whole Medicare Advantage group.

Earnings This Week: Sector Sentiment Snapshot and Forecast

Sector forecast: The back half of the week carries the heaviest implied moves: about 17% for AppLovin, 11% to 14% for Cloudflare, IonQ, SoundHound and Oklo, and under 10% for Qualcomm, Airbnb and Humana. Friday’s 8:30 a.m. ET jobs report then resets rate expectations, and Berkshire Hathaway has yet to set a date; its last report landed on a Saturday. For the software setup, see TNN’s Oct. 29 stocks to watch, and for smaller names, the Oct. 29 stocks under $6 list. New to earnings plays? Read our 7-step checklist for picking stocks and the earlier Oct. 23 earnings-reaction list.

Earnings This Week: At a Glance

Follow TNN for daily stock market news and financial news today.

Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss, and small-cap, high-volatility and event-driven stocks carry elevated risk, including dilution and total loss. Stock prices, percentage moves, and market data cited reflect figures available at the time of publication and are subject to change as trading continues. Options-implied moves are estimates of expected volatility, not predictions of direction, and some prices are derived or unverified and labeled as such. Earnings dates and times can change. Support and resistance levels are analytical zones, not predictions. Analyst price targets and ratings are third-party estimates and do not guarantee actual results. Always complete independent due diligence prior to executing equity trades.

About The Author

Kasia Davis

See author's posts